FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606523079> ?p ?o ?g. }

• W2606523079 abstract "Meningococcal C conjugate (MCC) vaccination programs provide direct and indirect protection against meningococcal disease. However, a decrease in the antibodies could affect herd immunity. We conducted a seroprevalence study to assess the immunity in subjects 8-12years after different MCCV vaccination programs were launched and evaluated the impact of vaccination on seroprotection.Seroepidemiological study conducted from October 2010 to April 2012 in the region of Valencia, Spain. Sample size was not proportional to the population but to the expected seroprotection by age group. Sera from subjects that were≥3years old were tested using a standardized complement-mediated serum bactericidal antibodies (SBA) assay. Age-stratified proportions of subjects with SBA titers≥8 were considered seroprotected and evaluated. A multivariate logistic regression model was performed to evaluate the impact of vaccination on the seroprotection.Serum samples from 1880 subjects were collected. In total, 523 (27.8%) of the 1880 subjects and 446 (31.2%) of the 1430 subjects<30years (targeted to any vaccination campaign) showed protective SBA titers. The highest percentage of seroprotected subjects (67.8%, 95%CI 56.9-77.4) was observed in those that were vaccinated in a catch-up campaign at 10-13years of age (20-21years old at the time of blood sampling). Those scheduled for immunization in infancy at 2, 4 and 6months of age (7-8years at blood sample) represented the lowest (7.1%, 95% CI 3.3-13.1) number of seroprotected subjects. Having received one vaccine dose after 12months of age was associated with increased seroprotection. The present study revealed a positive correlation between the increasing age at vaccination and longer duration of seroprotection.Only one in three subjects who were vaccinated with MCC vaccine was seroprotected after 8-12years. These findings emphasize that seroprevalence studies are essential to identify susceptible cohorts and to inform vaccine policy." @default.
• W2606523079 created "2017-04-28" @default.
• W2606523079 creator A5005786591 @default.
• W2606523079 creator A5011800738 @default.
• W2606523079 creator A5033658596 @default.
• W2606523079 creator A5044278213 @default.
• W2606523079 creator A5050902775 @default.
• W2606523079 creator A5053247916 @default.
• W2606523079 creator A5058848131 @default.
• W2606523079 creator A5064972009 @default.
• W2606523079 creator A5067144248 @default.
• W2606523079 date "2017-05-01" @default.
• W2606523079 modified "2023-09-27" @default.
• W2606523079 title "Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination" @default.
• W2606523079 cites W1847595 @default.
• W2606523079 cites W1912692997 @default.
• W2606523079 cites W1914544186 @default.
• W2606523079 cites W1963888311 @default.
• W2606523079 cites W1972573890 @default.
• W2606523079 cites W1976085123 @default.
• W2606523079 cites W1992790837 @default.
• W2606523079 cites W1998120547 @default.
• W2606523079 cites W2025502898 @default.
• W2606523079 cites W2027737390 @default.
• W2606523079 cites W2030178991 @default.
• W2606523079 cites W2031697639 @default.
• W2606523079 cites W2041396296 @default.
• W2606523079 cites W2047369361 @default.
• W2606523079 cites W2052139850 @default.
• W2606523079 cites W2056413403 @default.
• W2606523079 cites W2061372708 @default.
• W2606523079 cites W2068368401 @default.
• W2606523079 cites W2079174856 @default.
• W2606523079 cites W2091543537 @default.
• W2606523079 cites W2091951392 @default.
• W2606523079 cites W2102748782 @default.
• W2606523079 cites W2116995839 @default.
• W2606523079 cites W2118619617 @default.
• W2606523079 cites W2128589740 @default.
• W2606523079 cites W2129094433 @default.
• W2606523079 cites W2133246148 @default.
• W2606523079 cites W2134945394 @default.
• W2606523079 cites W2135324528 @default.
• W2606523079 cites W2137586712 @default.
• W2606523079 cites W2139539689 @default.
• W2606523079 cites W2141563230 @default.
• W2606523079 cites W2160879811 @default.
• W2606523079 cites W2169859589 @default.
• W2606523079 cites W2171028861 @default.
• W2606523079 cites W2296201308 @default.
• W2606523079 doi "https://doi.org/10.1016/j.vaccine.2017.04.022" @default.
• W2606523079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28438407" @default.
• W2606523079 hasPublicationYear "2017" @default.
• W2606523079 type Work @default.
• W2606523079 sameAs 2606523079 @default.
• W2606523079 citedByCount "1" @default.
• W2606523079 countsByYear W26065230792018 @default.
• W2606523079 crossrefType "journal-article" @default.
• W2606523079 hasAuthorship W2606523079A5005786591 @default.
• W2606523079 hasAuthorship W2606523079A5011800738 @default.
• W2606523079 hasAuthorship W2606523079A5033658596 @default.
• W2606523079 hasAuthorship W2606523079A5044278213 @default.
• W2606523079 hasAuthorship W2606523079A5050902775 @default.
• W2606523079 hasAuthorship W2606523079A5053247916 @default.
• W2606523079 hasAuthorship W2606523079A5058848131 @default.
• W2606523079 hasAuthorship W2606523079A5064972009 @default.
• W2606523079 hasAuthorship W2606523079A5067144248 @default.
• W2606523079 hasConcept C106192422 @default.
• W2606523079 hasConcept C126322002 @default.
• W2606523079 hasConcept C151956035 @default.
• W2606523079 hasConcept C159654299 @default.
• W2606523079 hasConcept C203014093 @default.
• W2606523079 hasConcept C22070199 @default.
• W2606523079 hasConcept C2778458888 @default.
• W2606523079 hasConcept C2778494684 @default.
• W2606523079 hasConcept C2780454893 @default.
• W2606523079 hasConcept C2780801004 @default.
• W2606523079 hasConcept C2908647359 @default.
• W2606523079 hasConcept C32611913 @default.
• W2606523079 hasConcept C45189115 @default.
• W2606523079 hasConcept C523546767 @default.
• W2606523079 hasConcept C54355233 @default.
• W2606523079 hasConcept C71924100 @default.
• W2606523079 hasConcept C86803240 @default.
• W2606523079 hasConcept C99454951 @default.
• W2606523079 hasConceptScore W2606523079C106192422 @default.
• W2606523079 hasConceptScore W2606523079C126322002 @default.
• W2606523079 hasConceptScore W2606523079C151956035 @default.
• W2606523079 hasConceptScore W2606523079C159654299 @default.
• W2606523079 hasConceptScore W2606523079C203014093 @default.
• W2606523079 hasConceptScore W2606523079C22070199 @default.
• W2606523079 hasConceptScore W2606523079C2778458888 @default.
• W2606523079 hasConceptScore W2606523079C2778494684 @default.
• W2606523079 hasConceptScore W2606523079C2780454893 @default.
• W2606523079 hasConceptScore W2606523079C2780801004 @default.
• W2606523079 hasConceptScore W2606523079C2908647359 @default.
• W2606523079 hasConceptScore W2606523079C32611913 @default.
• W2606523079 hasConceptScore W2606523079C45189115 @default.
• W2606523079 hasConceptScore W2606523079C523546767 @default.
• W2606523079 hasConceptScore W2606523079C54355233 @default.

• next